72 results
8-K
EX-99.1
FENC
Fennec Pharmaceuticals Inc
21 Mar 24
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
4:02pm
-twenties
Enhances Norgine’s commitment to bringing transformative therapies to patients in Europe, U.K., Australia, and New Zealand who currently do … . Commitment to transforming people’s lives drives everything Norgine does with fully integrated infrastructure and exceptional partnership approach
424B7
FENC
Fennec Pharmaceuticals Inc
15 Mar 24
Prospectus with selling stockholder info
3:53pm
as payment of our commitment fee under the SPA. The Warrants grant the selling stockholder the right to purchase up to 110,996 shares of our common shares … transactions;
through broker/dealers, who may act as agents or principals;
through one or more underwriters on a firm commitment or best-efforts basis
8-K
EX-10.1
w1q0a9x86v39jny1tom
5 Dec 23
Fennec Announces Incremental $5 Million Investment from Petrichor
8:51pm
8-K/A
EX-99.1
tiqh5xf
7 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:51am
8-K
EX-99.1
ss7pbhh
4 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:58am
8-K
EX-99.1
crl4 kane
4 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:57am
8-K
8dhan6
26 Sep 22
Fennec Pharmaceuticals Announces Second Closing of $20 Million Investment
5:03pm
8-K
l4u 8ilo7tu
22 Aug 22
Fennec Pharmaceuticals Closes First $5 Million Investment
9:00am